CMV neurologic disease: Difference between revisions

(Created page with "==Background== ==Clinical Presentation== ==Differential Diagnosis== ==Diagnosis== ==Management== ===Antivirals=== {{CMV neurologic disease treatment}} ==Disposition== =...")
 
 
(8 intermediate revisions by 4 users not shown)
Line 1: Line 1:
==Background==
==Background==


==Clinical Presentation==
==Clinical Features<ref>https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545043/all/CMV__neurologic</ref>==
*Typically presents in immunocompromised hosts (e.g. [[AIDS]]) with history of prior CMV illness (e.g. [[CMV retinitis]]
*Usually [[encephalitis]], presenting as a acute, rapid onset, progressive [[encephalopathy]] but can also manifest as polyradiculitis
*Encephalitis:
**Memory impairment with [[dementia]]-like presentation
**[[weakness|Motor deficits]], [[numbness]], [[cranial nerve palsies]]
**[[Ataxia]], [[nystagmus]]
**[[intracranial mass|Mass lesion]] with focal deficits or evidence of mass effect
**+/- [[Fever]]
*Polyradiculitis
**[[Back pain]]/sciatica
**[[Paresthesia]], distal [[numbness|sensory loss]]
**[[Urinary retention]]
**Ascending [[weakness|paralysis]], similar to [[Guillain-Barre]]


==Differential Diagnosis==
==Differential Diagnosis==
{{AMS and fever DDX}}
{{HIV associated conditions}}


==Diagnosis==
==Evaluation==
*Neuroimaging ([[brain MRI|MRI]] more helpful than [[head CT|CT]])
*CMV PCR


==Management==
==Management==
Line 12: Line 29:


==Disposition==
==Disposition==
 
*Admit


==See Also==
==See Also==
*[[Cytomegalovirus (CMV) infection]]


==External Links==
==External Links==
Line 20: Line 38:
==References==
==References==
<references/>
<references/>
[[Category:ID]] [[Category:Neurology]]

Latest revision as of 00:35, 3 October 2019

Background

Clinical Features[1]

Differential Diagnosis

Altered mental status and fever

HIV associated conditions

Evaluation

  • Neuroimaging (MRI more helpful than CT)
  • CMV PCR

Management

Antivirals

  • Ganciclovir 5mg/kg IV q12hrs x 21 days then 5mg/kg IV q24hrs +
    • Foscarnet 90mg/kg IV q12hrs x 21 days then 90-120mg/kg IV q24hrs

Disposition

  • Admit

See Also

External Links

References

  1. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545043/all/CMV__neurologic
  2. Gutteridge, David L MD, MPH, Egan, Daniel J. MD. The HIV-Infected Adult Patient in The Emergency Department: The Changing Landscape of the Disease. Emergency Medicine Practice: An Evidence-Based Approach to Emergency Medicine. Vol 18, Num 2. Feb 2016.